Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-121818
Filing Date
2020-11-05
Accepted
2020-11-05 16:22:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2024584-8_s1a.htm S-1/A 2996008
2 EXHIBIT 5.1 tm2024584d8_ex5-1.htm EX-5.1 12184
3 EXHIBIT 23.1 tm2024584d8_ex23-1.htm EX-23.1 2585
4 GRAPHIC tm2024584d1-fc_develop4clr.jpg GRAPHIC 1800653
5 GRAPHIC tm2024584d1-fc_mechani4clr.jpg GRAPHIC 2385900
6 GRAPHIC tm2024584d1-fc_targets4clr.jpg GRAPHIC 3168837
7 GRAPHIC tm2024584d1-fc_pufabwlr.jpg GRAPHIC 595251
8 GRAPHIC image_001.jpg GRAPHIC 3449
  Complete submission text file 0001104659-20-121818.txt   13964784
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
NEUROTROPE BIOSCIENCE, INC. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-249434 | Film No.: 201290802
SIC: 2834 Pharmaceutical Preparations